de Bardeci, Mateo
Greil, Waldemar http://orcid.org/0000-0003-2342-735X
Stassen, Hans
Willms, Jamila
Köberle, Ursula
Bridler, René
Hasler, Gregor
Kasper, Siegfried
Rüther, Eckart
Bleich, Stefan
Toto, Sermin
Grohmann, Renate
Seifert, Johanna
Funding for this research was provided by:
Universitätsklinik München
Article History
Received: 20 August 2021
Accepted: 4 February 2022
First Online: 25 February 2022
Declarations
:
: GH has received honoraria from Lundbeck, Servier, Takeda, Otsuka, Schwabe, Janssen, Sunovion, Vifor, Desitin Pharma, Sanofi, and Recordati. SK has received grants/research support, consulting fees and/or honoraria within the last three years; grant/research support from Lundbeck; he has served as a consultant or on advisory boards Celegne, IQVIA, Janssen, Lundbeck, Mundipharma, Recordati, Takeda and Schwabe; and he has served on speakers bureaus for Angelini, Aspen Farmaceutica S.A., Janssen, Krka Pharma, Lundbeck, Medichem Pharmaceuticals Inc., Neuraxpharma, OM Pharma, Pierre Fabre, Sanofi, Servier, Schwabe, and Sun Pharma. JS has taken part in an educational event sponsored by Lundbeck/Otsuka. ST is a member of the advisory board for Otsuka and Janssen-Cilag and has received speaker’s honoraria from Janssen-Cilag, Lundbeck/Otsuka, Recordati Pharma GmbH, and Servier. All other authors state they have no conflicts of interest to declare.
: See methods: data source.